newsfilter
← Latest News
GlobeNewswire·

InMed Provides Business Update and Milestones for 2023

Complete Phase 2 clinical trial enrollment in Epidermolysis Bullosa in 1Q 2023Progress preclinical research in glaucoma in preparation for human trialsAdvance research using rare cannabinoids in treating